Nov 18, 2021 8:30am EST Veru to Report Fiscal 2021 Fourth-Quarter, Full-Year Financial Results, Host Conference Call on December 2nd
Nov 18, 2021 8:00am EST Veru Ranked as one of the Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500
Nov 08, 2021 8:30am EST Veru to Participate in Fireside Chat at the Jefferies London Healthcare Conference on November 16-18, 2021
Oct 13, 2021 8:30am EDT Veru Enrolls First Patient in International Phase 3 ARTEST Clinical Trial of Enobosarm in Metastatic Breast Cancer
Sep 20, 2021 8:30am EDT Veru Announces Positive Updated Data from Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Sep 09, 2021 8:30am EDT Veru Announces Oral Presentation of Updated Data from the Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Aug 12, 2021 6:30am EDT Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 Third Quarter
Jul 29, 2021 8:30am EDT Veru to Report Fiscal 2021 Third-Quarter Financial Results, Host Conference Call on August 12th
